theflyonthewall.com: the Fastest Breaking Financial and Equity News on the Web

News Breaks

09:05 EDT

SQNM

theflyonthewall.com:		Sequenom shares recent rise unfounded, says Hapoalim
		Hapoalim believes the recent rally in Sequenom shares is unfounded as the company has issued no public statements regarding the status of its Down syndrome test. The firm attributes recent trading to rumors and reiterates a Sell rating on the stock with a $1.50 price target. :theflyonthewall.com

News For SQNM From The Last 14 Days

Check below for free stories on SQNM the last two weeks.

There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.

February 9, 2010

08:32 EDT

SQNM

theflyonthewall.com:		Sequenom licenses rights to develop age-related macular degeneration test
		Subscribe for More Information :theflyonthewall.com

February 4, 2010

10:55 EDT

SQNM

theflyonthewall.com:		Sequenom launches SensiGene Fetal RHD Genotyping Test
		Subscribe for More Information :theflyonthewall.com